A Phase I, Open-Label, Multiple-Ascending Dose Trial To Investigate The Safety, Tolerability, Pharmacokinetics, Biological And Clinical Activity Of Ms
Posted Date: May 15, 2019
- Investigator: John Morris
- Type of Study: Drug
The research study is testing the investigational drug MSB0010718C, given in the treatment of solid tumors. The word ?investigational? means the drug is not approved by United States Food and Drug Administration (FDA) and is still being tested for safety and effectiveness. The main purpose of this
Criteria:
Qualified Participants Must Be At Least 18 Years Of Age And Have A Advanced Cancer.
Keywords:
Emr100070-001, Metastatic, Phase I, Gi, Gastric
For More Information:
Uc Cancer Center
513-584-7698
kastla@ucmail.uc.edu